Open the mobile version, with barcode scanning
Class II Ongoing

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Dee…

Why: CGMP Deviations

Company
Baxter Healthcare Corporation
Deerfield, IL, United States
Reported
Sep 9, 2026
Recall started
Aug 6, 2026
Where sold
US Nationwide; Puerto Rico; and Chile.
Amount
N/A
Full product description
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.
Lots / codes affected
Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.